Matches in SemOpenAlex for { <https://semopenalex.org/work/W4328102480> ?p ?o ?g. }
- W4328102480 endingPage "428" @default.
- W4328102480 startingPage "415" @default.
- W4328102480 abstract "Ramucirumab plus erlotinib (RAM+ERL) demonstrated superior progression-free survival (PFS) in RELAY, a randomised Phase III trial in patients with untreated, metastatic, EGFR-mutated, non-small-cell lung cancer (EGFR+ NSCLC). Here, we present the relationship between TP53 status and outcomes in RELAY.Patients received oral ERL plus intravenous RAM (10 mg/kg IV) or placebo (PBO+ERL) every 2 weeks. Plasma was assessed by Guardant 360 next-generation sequencing and patients with any gene alteration detected at baseline were included in this exploratory analysis. Endpoints included PFS, overall response rate (ORR), disease control rate (DCR), DoR, overall survival (OS), safety, and biomarker analysis. The association between TP53 status and outcomes was evaluated.Mutated TP53 was detected in 165 (42.7%; 74 RAM+ERL, 91 PBO+ERL) patients, wild-type TP53 in 221 (57.3%; 118 RAM+ERL, 103 PBO+ERL) patients. Patient and disease characteristics and concurrent gene alterations were comparable between those with mutant and wildtype TP53. Independent of treatment, TP53 mutations, most notably on exon 8, were associated with worse clinical outcomes. In all patients, RAM+ERL improved PFS. While ORR and DCR were comparable across all patients, DoR was superior with RAM+ERL. There were no clinically meaningful differences in the safety profiles between those with baseline TP53 mutation and wild-type.This analysis indicates that while TP53 mutations are a negative prognostic marker in EGFR+ NSCLC, the addition of a VEGF inhibitor improves outcomes in those with mutant TP53. RAM+ERL is an efficacious first-line treatment option for patients with EGFR+ NSCLC, independent of TP53 status." @default.
- W4328102480 created "2023-03-22" @default.
- W4328102480 creator A5001428569 @default.
- W4328102480 creator A5036031726 @default.
- W4328102480 creator A5052765751 @default.
- W4328102480 creator A5055152134 @default.
- W4328102480 creator A5060287300 @default.
- W4328102480 creator A5060572768 @default.
- W4328102480 creator A5068540628 @default.
- W4328102480 creator A5072452238 @default.
- W4328102480 creator A5075536764 @default.
- W4328102480 creator A5078287634 @default.
- W4328102480 date "2023-07-01" @default.
- W4328102480 modified "2023-10-18" @default.
- W4328102480 title "RELAY, Ramucirumab Plus Erlotinib (RAM+ERL) in Untreated Metastatic EGFR-Mutant NSCLC (EGFR+ NSCLC): Association Between TP53 Status and Clinical Outcome" @default.
- W4328102480 cites W1978322976 @default.
- W4328102480 cites W2004681996 @default.
- W4328102480 cites W2012944100 @default.
- W4328102480 cites W2016489352 @default.
- W4328102480 cites W2061932411 @default.
- W4328102480 cites W2091484472 @default.
- W4328102480 cites W2101657563 @default.
- W4328102480 cites W2115775023 @default.
- W4328102480 cites W2145979349 @default.
- W4328102480 cites W2154803909 @default.
- W4328102480 cites W2163186602 @default.
- W4328102480 cites W2192184960 @default.
- W4328102480 cites W2410893706 @default.
- W4328102480 cites W2504980652 @default.
- W4328102480 cites W2534288116 @default.
- W4328102480 cites W2581103010 @default.
- W4328102480 cites W2747505649 @default.
- W4328102480 cites W2770828094 @default.
- W4328102480 cites W2937223370 @default.
- W4328102480 cites W2943671268 @default.
- W4328102480 cites W2951812358 @default.
- W4328102480 cites W2952308182 @default.
- W4328102480 cites W2952506496 @default.
- W4328102480 cites W2976334328 @default.
- W4328102480 cites W2978256445 @default.
- W4328102480 cites W2978677918 @default.
- W4328102480 cites W2979074753 @default.
- W4328102480 cites W3015975085 @default.
- W4328102480 cites W3016720073 @default.
- W4328102480 cites W3032267707 @default.
- W4328102480 cites W3043937496 @default.
- W4328102480 cites W3046244298 @default.
- W4328102480 cites W3092965608 @default.
- W4328102480 cites W3094019790 @default.
- W4328102480 cites W3105369138 @default.
- W4328102480 cites W3113022089 @default.
- W4328102480 cites W3119649652 @default.
- W4328102480 cites W3121060134 @default.
- W4328102480 cites W3137245097 @default.
- W4328102480 cites W3141598567 @default.
- W4328102480 cites W3162167726 @default.
- W4328102480 cites W3165543715 @default.
- W4328102480 cites W3191778845 @default.
- W4328102480 cites W3201822124 @default.
- W4328102480 cites W3204862279 @default.
- W4328102480 cites W3209185952 @default.
- W4328102480 cites W4210992155 @default.
- W4328102480 cites W4280533169 @default.
- W4328102480 doi "https://doi.org/10.1016/j.cllc.2023.02.010" @default.
- W4328102480 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37076395" @default.
- W4328102480 hasPublicationYear "2023" @default.
- W4328102480 type Work @default.
- W4328102480 citedByCount "4" @default.
- W4328102480 countsByYear W43281024802023 @default.
- W4328102480 crossrefType "journal-article" @default.
- W4328102480 hasAuthorship W4328102480A5001428569 @default.
- W4328102480 hasAuthorship W4328102480A5036031726 @default.
- W4328102480 hasAuthorship W4328102480A5052765751 @default.
- W4328102480 hasAuthorship W4328102480A5055152134 @default.
- W4328102480 hasAuthorship W4328102480A5060287300 @default.
- W4328102480 hasAuthorship W4328102480A5060572768 @default.
- W4328102480 hasAuthorship W4328102480A5068540628 @default.
- W4328102480 hasAuthorship W4328102480A5072452238 @default.
- W4328102480 hasAuthorship W4328102480A5075536764 @default.
- W4328102480 hasAuthorship W4328102480A5078287634 @default.
- W4328102480 hasBestOaLocation W43281024801 @default.
- W4328102480 hasConcept C121608353 @default.
- W4328102480 hasConcept C126322002 @default.
- W4328102480 hasConcept C143998085 @default.
- W4328102480 hasConcept C2776256026 @default.
- W4328102480 hasConcept C2778087573 @default.
- W4328102480 hasConcept C2779438470 @default.
- W4328102480 hasConcept C2779551604 @default.
- W4328102480 hasConcept C2780586478 @default.
- W4328102480 hasConcept C2780739268 @default.
- W4328102480 hasConcept C3019894029 @default.
- W4328102480 hasConcept C71924100 @default.
- W4328102480 hasConceptScore W4328102480C121608353 @default.
- W4328102480 hasConceptScore W4328102480C126322002 @default.
- W4328102480 hasConceptScore W4328102480C143998085 @default.
- W4328102480 hasConceptScore W4328102480C2776256026 @default.
- W4328102480 hasConceptScore W4328102480C2778087573 @default.
- W4328102480 hasConceptScore W4328102480C2779438470 @default.